简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Video
Research
Latest
19:04
【SUNEVISION (01686.HK): Sun Hung Kai Properties group to convert all convertible notes; public float to decrease to approximately 15.1029%】On 11 September 2026, SUNEVISION (01686.HK) announced that the wholly-owned subsidiary of its controlling shareholder, Sun Hung Kai Properties, has exercised its rights to convert all of its convertible notes in an aggregate amount of HKD 171,942,750.00 into 1,719,427,500 new shares, with the conversion date set at 27 October 2026, and that the public float of the Company will decrease to approximately 15.1029%.
Tag:
SUNEVISION
01686.HK
Share issuance
Public Float
Share:
18:59
【CHINA OVERSEAS (00688.HK): Proposed spin-off approved by the Stock Exchange; assured entitlement waiver granted】On 11 September 2026, CHINA OVERSEAS (00688.HK) announced that the Stock Exchange has confirmed that the Company may proceed with the proposed spin-off on the Shenzhen Stock Exchange under Practice Note 15, and has granted the Company a waiver from strict compliance with paragraph 3(f) of Practice Note 15 regarding the requirement to provide an assured entitlement to shareholders.
Tag:
CHINA OVERSEAS
00688.HK
Spin-off
Share:
18:53
【TECHTRONIC IND (00669.HK): Board lot size to change from 500 shares to 100 shares with effect from 5 October】On 11 September 2026, TECHTRONIC IND (00669.HK) announced that the board lot size of its shares for trading on the Main Board of the Stock Exchange will be changed from 500 shares to 100 shares with effect from 9:00 a.m. on 5 October 2026, reducing the market value of each board lot from HKD 63,500 to HKD 12,700 based on the closing price of HKD 127.00 per share on the date of the announcement.
Tag:
TECHTRONIC IND
00669.HK
Change of Board Lot Size
Share:
18:49
【SHENGLONG INTL (08481.HK): Land of Lin'an, Hangzhou plant resumed by the government; total compensation of approximately RMB 364 million】On 11 September 2026, SHENGLONG INTL (08481.HK) published an inside information announcement on the receipt of land resumption compensation, under which the People's Government of Lin'an District, Hangzhou required its indirect wholly-owned subsidiary Zhejiang Shenglong to relocate its decorative paper manufacturing plant at No. 55, Shangyang Road, with total compensation of approximately RMB 364 million, of which approximately RMB 181 million has been received.
Tag:
SHENGLONG INTL
08481.HK
Land Resumption Compensation
Share:
18:45
【TINCI (002709.SZ): CSRC confirms overseas listing filing; up to 412,760,200 overseas-listed ordinary shares to be issued for listing on the Hong Kong Stock Exchange】On 11 September 2026, the International Cooperation Department of the CSRC released a filing notice on overseas issuance and listing (Guohehan [2026] No. 1985, dated 18 August 2026), confirming the overseas issuance and listing filing of TINCI (002709.SZ), which intends to issue no more than 412,760,200 overseas-listed ordinary shares for listing on the Hong Kong Stock Exchange.
Tag:
TINCI
002709.SZ
A+H
IPO
境外发行上市备案通知书
Share:
18:34
【PKU RESOURCES (00618.HK): Executive Director Hou Ruilin resigns; Xiong Yan appointed as Executive Director】On 11 September 2026, PKU RESOURCES (00618.HK) announced that executive director Mr. Hou Ruilin resigned with effect from 11 September 2026 to devote more time to his personal affairs, and that Ms. Xiong Yan was appointed as an executive director on the same date at an annual director's remuneration of HKD 1.00.
Tag:
PKU RESOURCES
00618.HK
Board Change
Share:
18:21
【FUJING HOLDINGS (02497.HK): Executive Director and Financial Controller Lyu Zhonghua resigns with effect from 10 September 2026】On 11 September 2026, FUJING HOLDINGS (02497.HK) announced that executive director and Financial Controller Mr. Lyu Zhonghua decided to resign with effect from 10 September 2026 after considering his other personal work arrangements, and the Company is identifying a suitable candidate to fill the vacancy in the position of Financial Controller.
Tag:
FUJING HOLDINGS
02497.HK
Board Changes
Share:
18:03
【SEAZEN (01030.HK): Cumulative rental income reaches approximately RMB 9 billion in first eight months; cumulative contracted sales approximately RMB 8.107 billion】On 11 September 2026, SEAZEN (01030.HK) announced unaudited operating data for August 2026, with 183 investment properties totalling approximately 16.9092 million sqm and monthly rental income of approximately RMB 1.206 billion and commercial operation revenue of approximately RMB 1.291 billion; for January to August 2026, cumulative rental income was approximately RMB 9.000 billion and cumulative commercial operation revenue approximately RMB 9.644 billion, while August contracted sales were approximately RMB 889 million over approximately 140,900 sqm and cumulative contracted sales reached approximately RMB 8.107 billion over approximately 1,305,400 sqm.
Tag:
SEAZEN
01030.HK
Operating Data
Share:
17:59
【FOSUN PHARMA (02196.HK): Registration application for new specification of HLX14 denosumab biosimilar accepted by NMPA】On 11 September 2026, FOSUN PHARMA (02196.HK) announced that the NMPA has accepted the drug registration application for the 120mg (1.7ml) vial specification of HLX14, a recombinant anti-RANKL fully human monoclonal antibody injection developed by its subsidiary Henlius as a denosumab biosimilar, covering all indications of the reference product Xgeva approved in mainland China; HLX14 (60mg/mL and 120mg/1.7mL) is already approved in the US, EU, UK and Canada, the group's cumulative R&D investment reached approximately RMB 352 million as at August 2026, and global denosumab sales were approximately USD 8.092 billion in 2025.
Tag:
FOSUN PHARMA
02196.HK
R&D Progress
Share:
17:54
【SHUI ON LAND (00272.HK): Disposes of Chongqing Yuzhong District commercial property for RMB 201 million in discloseable transaction】On 11 September 2026, SHUI ON LAND (00272.HK) announced the sale of the commercial property at Levels 1 to 6, No. 6 Ruitian Road, Yuzhong District, Chongqing, with a total GFA of 31,286.56 sqm, to Chongqing Shengjugé Real Estate Brokerage for approximately RMB 201,000,000 (approximately HKD 232,682,000) with a RMB 35,000,000 deposit; the property had a carrying amount of approximately RMB 190,000,000 as at 30 June 2026, no material gain or loss is expected, net cash inflow of approximately RMB 179,000,000 will be used for general working capital and annual revenue will fall by approximately RMB 14,000,000, with the disposal constituting a discloseable transaction exempt from circular and shareholders' approval.
Tag:
SHUI ON LAND
00272.HK
Disposal of Assets
Share:
17:53
【Going Global Weekly: Pharma Licensing and Overseas Registrations Land in Cluster, Manufacturing Capacity Expansion in Southeast Asia Accelerates-20260911】This week's Going Global Weekly contains 10 items, with pharmaceuticals and manufacturing forming the two main lines. On the pharmaceutical side, LEE'S PHARM obtained an exclusive licence from 1cBio, STAR SPORTS MED obtained EU CE MDR certification for its full product portfolio, and ASCLETIS-B and CLOVER BIO-B advanced their overseas clinical programmes in parallel; on the manufacturing side, FOUNTAIN SET acquired an 81% equity interest in a Vietnamese textile company for US$27.945 million, and ANJOY FOOD plans to contribute US$37.49625 million to establish a joint-venture production subsidiary in Indonesia. In terms of equity and financing, FOSUN PHARMA sold a 6% stake in India's Gland Pharma for approximately US$294 million, reducing its shareholding to approximately 45.76% while maintaining its controlling position.
Tag:
Going Global Weekly
FOUNTAIN SET
LEES PHARM
Share:
17:52
【SHENZHEN INT'L (00152.HK): Completes issuance of RMB 1 billion medium-term notes (tranche four) at 2.07%】On 11 September 2026, SHENZHEN INT'L (00152.HK) announced the completion of its 2026 fourth tranche of medium-term notes, comprising RMB 1 billion with a coupon rate of 2.07% and a 10-year term; the company had obtained approval to register multi-variety debt financing instruments of up to RMB 10 billion and has previously issued its 2024 first tranche (RMB 4 billion) and 2026 first to third tranches (RMB 1 billion, RMB 2 billion and RMB 1 billion), with issuance documents published on ChinaMoney and the Shanghai Clearing House website.
Tag:
SHENZHEN INT
00152.HK
Bond Issuance
Share:
17:47
【SHIMAO GROUP (00813.HK): Contracted sales reach approximately RMB 9.721 billion in first eight months; RMB 710 million in August】On 11 September 2026, SHIMAO GROUP (00813.HK) announced unaudited operating data for the eight months ended 31 August 2026, with cumulative contracted sales of approximately RMB 9.721 billion, cumulative contracted sales area of 792,172 sqm and an average selling price of RMB 12,271 per sqm, while August 2026 contracted sales were approximately RMB 710 million over 58,969 sqm at an average price of RMB 12,045 per sqm; the company noted the data is unaudited and may differ from figures in its audited financial statements, and is for reference only.
Tag:
SHIMAO GROUP
00813.HK
Operating Data
Share:
17:45
【ALI HEALTH (00241.HK): Yu Yong appointed executive director, chairman and CEO; Shen Difan resigns from those roles】On 11 September 2026, ALI HEALTH (00241.HK) announced that with effect from the close of business that day, Mr. Yu Yong was appointed executive director, chairman, CEO, chairman of the nomination committee and authorised representative, while Mr. Shen Difan resigned from those roles but remains an executive director; Mr. Yu, aged 50, joined the Alibaba Group in March 2005 and served as CEO and president of 1688.com from February 2022 to September 2026, with his executive director appointment running for one year from 11 September 2026, and the company disclosed that combining the chairman and CEO roles deviates from Rule C.2.1 of the Corporate Governance Code.
Tag:
ALI HEALTH
00241.HK
Board Change
Share:
17:39
【CHUNLI MEDICAL (01858.HK): Passing of company secretary, authorised representative and process agent Mr. Yip Pui Sum】On 11 September 2026, CHUNLI MEDICAL (01858.HK) announced that Mr. Yip Pui Sum, its company secretary, authorised representative under Rule 3.05 of the Listing Rules and process agent under Part 16 of the Companies Ordinance and Rule 19A.13(2), was confirmed to have passed away on 10 September 2026 after more than ten years of service; with no company secretary or process agent and only one authorised representative remaining, the company will not comply with Rules 3.28, 3.05 and 19A.13(2) and sections 474 and Part 16 of the Companies Ordinance, and the board will identify suitable candidates as soon as practicable.
Tag:
CHUNLI MEDICAL
01858.HK
Board Change
Share:
17:38
【S HARBOURHOLD (01663.HK): Chairman Wang Linbing increases shareholding by 7.684 million shares at average price of approximately HKD 0.062】On 11 September 2026, S HARBOURHOLD (01663.HK) announced that chairman and substantial shareholder Mr. Wang Linbing purchased an aggregate of 7,684,000 ordinary shares on the open market at an average price of approximately HKD 0.062 per share and a maximum price of HKD 0.063; Mr. Wang is the husband of substantial shareholder Ms. Chen Xiangling and the father of executive director Mr. Wang Lei, and the company reminded shareholders and investors to exercise caution when dealing in its securities.
Tag:
S HARBOURHOLD
01663.HK
Shareholding Increase
Share:
17:35
【PAN ASIA ENVIRO (00556.HK): Disposes of 51% equity interest in Xilailu Brand Management; terminates proposed name change】On 11 September 2026, PAN ASIA ENVIRO (00556.HK) announced the disposal of a 51% equity interest in Xilailu Brand Management (Guangzhou) Co., Ltd. and the decision not to proceed with a proposed change of company name or the related extraordinary general meeting; the announcement stated that the group had not obtained management control over or participated in the daily operations of the target company as at 30 June 2026, that the buyer obtained no control over daily operations, key records, chops, licences, bank accounts or financial systems and did not participate in marketing or franchise activities, and that the target's results have not been and will not be consolidated, with the disposal having no material impact on the group's business.
Tag:
PAN ASIA ENVIRO
00556.HK
Disposal of Assets
Name Change Termination
Share:
17:25
【CHONG FAI JEWEL (08537.HK): Fu Danling resigns as executive director with effect from 11 September】On 11 September 2026, CHONG FAI JEWEL (08537.HK) announced that Ms. Fu Danling has resigned as an executive director with effect from 11 September 2026 due to the need to devote more time to her other personal affairs and business commitments, having confirmed that she has no disagreement with the board or the company and that no other matters relating to her resignation need to be brought to shareholders' or the Stock Exchange's attention; as at the announcement date, the executive directors are Mr. Fu Chun Keung, Ms. Cheung Lai Yuk and Mr. Fu Ho Hon.
Tag:
CHONG FAI JEWEL
08537.HK
resignation
Share:
17:12
【SITOY GROUP (01023.HK): Profit Warning, Full-year Loss Attributable to Owners Expected to Narrow to HKD 110,000,000 to HKD 130,000,000】On 11 September 2026, SITOY GROUP (01023.HK) issued a profit warning, expecting a loss attributable to owners of the Company of approximately HKD 110,000,000 to HKD 130,000,000 for the year ended 30 June 2026, narrower than approximately HKD 178,074,000 in 2025, mainly because the one-off significant loss from terminating the Cole Haan business did not recur and the fair value loss on investment properties fell to approximately HKD 50,000,000 to HKD 55,000,000.
Tag:
SITOY GROUP
01023.HK
Narrowing Loss
Share:
17:08
【DIAGENS-B (02526.HK): Signs Three-Year Cooperation Framework Agreement with Anzhen'er on Provincial Medical Imaging AI Platform】On 11 September 2026, DIAGENS-B (02526.HK) announced that it has entered into a three-year cooperation framework agreement with Zhejiang Anzhen'er Medical Artificial Intelligence Technology Co., Ltd. covering medical imaging artificial intelligence, primary-level imaging cloud services and medical data products, with the parties intending to jointly build a Zhejiang provincial cloud platform for AI-assisted medical imaging diagnosis. No specific agreements have been entered into for specific cooperation projects.
Tag:
DIAGENS-B
02526.HK
strategic cooperation
Share:
Previous
1
2
3
4
5
..523
Next
523
pages total
Featured News
Overseas
Going Global Weekly: Pharma Licensing and Overseas Registrations Land in Cluster, Manufacturing Capacity Expansion in Southeast Asia Accelerates-20260911
Finance
SITOY GROUP (01023.HK): Profit Warning, Full-year Loss Attributable to Owners Expected to Narrow to HKD 110,000,000 to HKD 130,000,000
Finance
DIAGENS-B (02526.HK): Signs Three-Year Cooperation Framework Agreement with Anzhen'er on Provincial Medical Imaging AI Platform
Finance
HANSOH PHARMA (03692.HK): Small Cell Lung Cancer Product HS-20093 Included in NMPA Priority Review Procedure
Finance
UCD (01599.HK): Files with CSRC for H-share Full Circulation Involving 68,816,000 Domestic Unlisted Shares
Finance
CHOW TAI FOOK (01929.HK): Applies to Register and Proposes Issue of Panda Bonds of Up to RMB 10 Billion
Research
HK shares ETFs Daily Report: iShares Core MSCI China Index ETF Leads Alone, Up Over 1.5%, as AI and Semiconductor Names Come Under Broad Pressure — September 11, 2026
Research
Shanghai-Shenzhen Stock Connect ETFs Daily Report: Military and Communication Themes Gain Momentum; Non-Ferrous Metals Sector Plunges Collectively - 20260911
ETF
Tracker Fund Of Hong Kong (02800.HK) Falls 0.55% Intraday, AUM at HK$133.882 Billion
ETF
Ishares Ftse China A50 Etf (02823.HK) Falls 0.54% Intraday to HK$16.570
Scan QR Code
Download App
×
Share to WeChat
Open WeChat, use "Scan," and share to my Moments